Description
BSE announces securities entering and exiting Short Term Additional Surveillance Measure framework effective August 11, 2025.
Summary
BSE has updated its Short Term Additional Surveillance Measure (ST-ASM) framework effective August 11, 2025. Two new securities have been added to the ST-ASM framework while nine securities are moving out due to inclusion in other regulatory frameworks.
Key Points
- 2 securities newly shortlisted for ST-ASM framework (5/15/30 days)
- 9 securities moving out of ST-ASM framework
- All changes effective from August 11, 2025
- Securities moving out are being included in other regulatory frameworks (LT-ASM, Trade for Trade, GSM, ESM)
- Framework includes SME scrips and T+0 scrips based on parent company classification
Securities Added to ST-ASM
- Clinitech Laboratory Ltd (Code: 544220, ISIN: INE0QMR01015) - SME scrip
- Patels Airtemp India Ltd (Code: 517417, ISIN: INE082C01024)
Securities Removed from ST-ASM
- Bharat Parenterals Ltd
- Gallops Enterprise Ltd (moving to Trade for Trade Framework)
- Golden Legand Leasing & Finance Ltd (moving to Trade for Trade Framework)
- Incon Engineers Ltd (moving to LT-ASM Framework)
- KIFS Financial Services Ltd
- Krishna Capital and Securities Ltd (moving to LT-ASM Framework)
- MFS Intercorp Ltd (moving to GSM Framework)
- Neil Industries Ltd (moving to ESM Framework)
- Pondy Oxides & Chemicals Ltd
Regulatory Changes
Securities under ST-ASM framework are subject to enhanced monitoring and may face trading restrictions. The framework operates in stages with 5/15/30 day monitoring periods.
Important Dates
- August 11, 2025: Effective date for all ST-ASM framework changes
Impact Assessment
The changes will affect trading conditions for the listed securities. Investors and traders dealing with these securities should be aware of the enhanced surveillance measures and potential trading restrictions that may apply.
Impact Justification
Affects trading conditions for specific securities under surveillance framework